Sign in to view content

Efficacy, Safety, and Durability of Faricimab in Macular Edema Due to Retinal Vein Occlusion:72-Week Results From the Phase 3 BALATON and COMINO Trials

Carl J Danzig, MD

Video
Published 2024

Related

Intravitreal Aflibercept 8 mg for Diabetic Macular Edema: Week 48 Efficacy Outcomes by Baseline Demographics in the Phase 2/3 PHOTON Trial
Andres Emanuelli, MD
Annual Meeting Talks
2023
Faricimab Rapidly Improves Fluid Parameters in Patients With nAMD
Nikolas JS London, MD, FACS, FASRS
Annual Meeting Talks
2023
Aflibercept 8 mg in Treatment-Naive Macular Edema Secondary to Retinal Vein Occlusion: Primary Endpoint Results From the QUASAR Study
Seenu M. Hariprasad, MD
Annual Meeting Talks
2025

Category: Retinal Vascular Disease

See more